Janice Layhadi MSc, PhD

Dr Janice A. Layhadi is a Research Associate at the Immunomodulation and Tolerance Group (ITG) of Allergy & Clinical Immunology, NHLI. She completed her undergraduate studies in Biochemistry at Imperial College London and pursued a master's degree in Pharmacology at Oxford University. Dr Layhadi completed her PhD studies in molecular sciences and pharmacology at the University of East Anglia in 2017 and joined Professor Mohamed Shamji's group at Imperial College London.

Janice's research interest primarily involves identifying underpinning molecular mechanisms in innate lymphoid cells associated with immune tolerance. She has defined a new subset of innate lymphoid cells, IL-10 ILC2, that are induced following allergen immunotherapy and correlate with clinical efficacy. Dr Layhadi leads the single-cell multi-omic research and has identified novel biomarkers for AIT response. Her research has resulted in several peer-reviewed publications in high-impact journals within the field of Allergy. Her contribution towards the field of allergy has been internationally recognised in which she was made a recipient of the very prestigious EAACI Allergopharma Research Award in 2022.